Chapters

Transcript

Video

Bladder Cancer Advances

Dana-Farber's Guru Sonpavde, MD discusses two studies with promising results. One study looks at pre-operative therapy, the other study compares an antibody-drug conjugate to chemotherapy in urothelial carcinoma.

Related Presenters

Guru P. Sonpavde, MD.

Guru P. Sonpavde, MD

Medical Oncology

Guru P. Sonpavde, MD was the director of the bladder cancer program at Dana-Farber Cancer Institute and was on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus ...

View Profile

ADVERTISEMENT

Related Videos